LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Frank S. Wilton: New Chair of Donate Life America BOD
People In The News

Frank S. Wilton: New Chair of Donate Life America BOD

January 26, 2018 2 min read Premium comments

Advertisement

Frank S. Wilton: New Chair of Donate Life America BOD
Frank S. Wilton

Frank S. Wilton, president and CEO of the American Association of Tissue Banks (AATB), is the new chair of the Donate Life America (DLA) Board of Directors, representing the first time a representative from AATB has served in this role.

“In his previous years on the DLA Board, Frank has always made sure that resources were available to enable DLA to continue our mission—to drive individuals, organizations and communities to increase the number of designated organ, eye and tissue donors who save and heal lives,” said David Fleming, president and CEO of Donate Life America, in the January 11, 2018 news release. “We look forward to his continued engagement as chair.”

According to AATB: “Wilton has led the AATB as CEO since 2012 and, in that time, has visited more than 50 AATB-accredited tissue banks. He is a member of the U.S. Department of Health and Human Services Advisory Committee on Blood and Tissue Safety and Availability and has testified before Congress on the topic of tissue safety.”

“Wilton has more than 25 years of association, education and advocacy experience. Prior to joining AATB, he held several leadership positions at the Advanced Medical Technology Association (AdvaMed) and served as Executive Director of Label Printing Industries of America.”

“Wilton received his Certified Association Executive (CAE) designation from the American Society of Association Executives (ASAE) and his Institute of Management (IOM) designation from the U.S. Chamber of Commerce. He holds a master’s degree from Boston University and dual bachelor’s degrees from Hobart College. He and his wife live in Northern Virginia and have three grown children.”

Wilton told OTW, “After several years as the president and CEO of AATB, I was honored to initially join the Donate Life America Board back in 2014. My engagement over the past few years has provided me with vital insights into the changing world of organ, eye and tissue donation and the overall donation and transplantation community. As the first chair of DLA from the tissue banking profession, I feel compelled to help the general public gain a better understanding of the important and lifesaving benefits of tissue donation within the larger donation continuum.”

“My initial plans include reaching out to my fellow Board members—as well as the terrific DLA volunteers and staff—to gain the benefit of their counsel with respect to the challenges and opportunities facing DLA. One of my personal goals is to help people better understand that the decision to be a donor is the most important step—whether executed by the donor her/himself or by the donor family. Not everyone can be an organ donor—many more people are able to be cornea and tissue donors. All gifts are precious and we should continue to celebrate and honor the courageous and selfless nature of all donors.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy